Princeton Global Asset Management »

Aprea Therapeutics shares owned by Princeton Global Asset Management

Quarter-by-quarter ownership of Aprea Therapeutics shares owned by Princeton Global Asset Management from 13F filings

Historical chart of Princeton Global Asset Management investment in Aprea Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aprea Therapeutics held by Princeton Global Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aprea Therapeutics by Princeton Global Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $669 100 6.69
2023-12-31 $470 100 4.70
2023-09-30 $417 100 4.17
2023-06-30 $315 100 3.15
2023-03-31 $444 100 4.44

More positions owned by Princeton Global Asset Management

Microsoft Corp Stock (MSFT)
Broadcom Stock (AVGO)
Taiwan Semiconductor Mfg Adr (TSM)
Blackstone Stock (BX)
Johnson & Johnson Stock (JNJ)
Jpmorgan Chase & Co Stock (JPM)
Unitedhealth Group Stock (UNH)
Ishares Core Dividend Growth Etf Etf (DGRO)
Crh Plc Ord Stock (CRH)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Apple Stock (AAPL)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Watsco Stock (WSO)
Carlisle Cos Stock (CSL)
Visa Inc Com Cl A Stock (V)

View all positions for Princeton Global Asset Management

Top funds holding Aprea Therapeutics

Nbc Securities
Princeton Global Asset Management

View all funds holding Aprea Therapeutics